THE PROGNOSTIC SIGNIFICANCE OF THE NUMBER OF EXTRANODAL INVOLVEMENT SITES IN THE PATIENTS WITH DISSEMINATED DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP

被引:0
|
作者
Yoo, C. [1 ]
Sohn, B. S. [1 ]
Kim, J. E. [1 ]
Yoon, D. H. [1 ]
Kim, S. [1 ]
Lee, D. H. [1 ]
Kim, S. W. [1 ]
Suh, C. [1 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0994
引用
收藏
页码:400 / 401
页数:2
相关论文
共 50 条
  • [41] The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady
    Chung, Joo-Seop
    Ilic, Ivana
    Leppa, Sirpa
    Seki, Ritsuko
    Uccella, Silvia
    Xia, Zu-Guang
    Butera, James N.
    BLOOD, 2010, 116 (21) : 1679 - 1679
  • [42] Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP
    Park, Mi-Jung
    Park, Soon-Ho
    Park, Pil-Whan
    Seo, Yiel-Hea
    Kim, Kyung-Hee
    Seo, Ja-Young
    Jeong, Ji-Hun
    Kim, Moon Jin
    Ahn, Jeong-Yeal
    Hong, Junshik
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (09) : 733 - 738
  • [43] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [44] Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
    Camus, Vincent
    Tilly, Herve
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1047 - 1055
  • [45] Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma
    Morrison, Vicki A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1651 - 1658
  • [46] Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP
    Kadota, Tomohiro
    Seo, Sachiko
    Fuse, Hiroe
    Ishii, Genichiro
    Itoh, Kuniaki
    Yano, Tomonori
    Kaneko, Kazuhiro
    Tsukasaki, Kunihiro
    CANCER MEDICINE, 2019, 8 (03): : 982 - 989
  • [47] Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
    Lavacchi, Daniele
    Landini, Ida
    Perrone, Gabriele
    Roviello, Giandomenico
    Mini, Enrico
    Nobili, Stefania
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [48] Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP
    Song, Moo-Kon
    Chung, Joo-Seop
    Shin, Dong-Hoon
    Seol, Young-Mi
    Shin, Ho-Jin
    Choi, Young-Jin
    Cho, Goon-Jae
    LEUKEMIA & LYMPHOMA, 2009, 50 (01) : 54 - 61
  • [49] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Moonho
    Ahn, Yongchel
    Ahn, Heui-June
    Ha, Suk-Hun
    Oh, Ho-Suk
    Song, Jae-Seok
    Park, Woong-Sub
    Yi, Sang-Wook
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3167 - 3175
  • [50] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)